These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26068027)

  • 21. Experimental allergic encephalomyelitis and multiple sclerosis: immunoregulatory mechanisms and T cell repertoires.
    Salvetti M; Massacesi L
    Cell Immunol; 1992 Jun; 142(1):217-9. PubMed ID: 1586957
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mechanisms involved in the regulation of immune response in experimental autoimmune encephalomyelitis in mice].
    Tutaj M; Szczepanik M
    Postepy Hig Med Dosw (Online); 2006; 60():571-83. PubMed ID: 17115007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The T lymphocyte in experimental allergic encephalomyelitis.
    Zamvil SS; Steinman L
    Annu Rev Immunol; 1990; 8():579-621. PubMed ID: 2188675
    [No Abstract]   [Full Text] [Related]  

  • 24. The generation of the relapse in chronic relapsing experimental allergic encephalomyelitis and multiple sclerosis--parallels and differences.
    Suckling AJ; Kirby JA; Wilson NR; Rumsby MG
    Prog Clin Biol Res; 1984; 146():7-12. PubMed ID: 6609376
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluating the evidence for multiple sclerosis as an autoimmune disease.
    Altmann D
    Arch Neurol; 2005 Apr; 62(4):688; author reply 688-9. PubMed ID: 15824275
    [No Abstract]   [Full Text] [Related]  

  • 26. T cell receptor peptides for the vaccination therapy of multiple sclerosis.
    Brocke S
    Ernst Schering Res Found Workshop; 2000; (30):167-79. PubMed ID: 10943323
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunomodulatory effects of the ether phospholipid edelfosine in experimental autoimmune encephalomyelitis.
    Abramowski P; Steinbach K; Zander AR; Martin R
    J Neuroimmunol; 2014 Sep; 274(1-2):111-24. PubMed ID: 25086877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoreactive T cells in multiple sclerosis.
    Zhang J; Weiner HL; Hafler DA
    Int Rev Immunol; 1992; 9(3):183-201. PubMed ID: 1285060
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiple sclerosis and related disorders: evolving pathophysiologic insights.
    Bar-Or A
    Lancet Neurol; 2016 Jan; 15(1):9-11. PubMed ID: 26700897
    [No Abstract]   [Full Text] [Related]  

  • 30. From mishap to model: The origins and utility of experimental autoimmune encephalomyelitis.
    Walton EL
    Biomed J; 2015; 38(3):177-80. PubMed ID: 26068026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The adhesion- and degranulation-promoting adaptor protein and its role in the modulation of experimental autoimmune encephalomyelitis.
    Engelmann S; Togni M; Kliche S; Reinhold D; Schraven B; Reinhold A
    Crit Rev Immunol; 2015; 35(1):1-14. PubMed ID: 25746044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B; Nessler S; Zhou D; Kieseier B; Hartung HP
    Nat Clin Pract Neurol; 2006 Apr; 2(4):201-11. PubMed ID: 16932551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
    Rodríguez-Rodríguez Y; Suárez-Luis I
    Rev Neurol; 2003 Apr 1-15; 36(7):649-52. PubMed ID: 12666047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multiple sclerosis and experimental autoimmune encephalomyelitis].
    Béraud-Juven E
    Rev Prat; 1994 Jan; 44(1):69-74. PubMed ID: 8178062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
    Kassis I; Petrou P; Halimi M; Karussis D
    Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of immune mechanisms in the pathogenesis of disseminated sclerosis].
    D'iakonova IN; Matveeva TV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):66-70. PubMed ID: 6979141
    [No Abstract]   [Full Text] [Related]  

  • 37. [Involvement of NK and NKT cells in the pathogenesis of multiple sclerosis].
    Yamamura T
    Nihon Rinsho; 2003 Aug; 61(8):1329-34. PubMed ID: 12962019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
    Lukinović-Skudar V; Taradi SK; Andreis I; Zupancić V; Taradi M
    Lijec Vjesn; 2001; 123(3-4):81-8. PubMed ID: 11488222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B cells in spontaneous autoimmune diseases of the central nervous system.
    Berer K; Wekerle H; Krishnamoorthy G
    Mol Immunol; 2011 Jun; 48(11):1332-7. PubMed ID: 21146219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
    Stuerzebecher S; Martin R
    Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.